Citation: W. Emlen et L. Oneill, CLINICAL-SIGNIFICANCE OF ANTINUCLEAR ANTIBODIES - COMPARISON OF DETECTION WITH IMMUNOFLUORESCENCE AND ENZYME-LINKED IMMUNOSORBENT ASSAYS, Arthritis and rheumatism, 40(9), 1997, pp. 1612-1618
Citation: L. Choi et al., BINDING OF ANTIPHOSPHOLIPID ANTIBODIES TO APOPTOTIC CELLS REQUIRES BETA-2GP1 COFACTOR, Journal of investigative medicine, 44(1), 1996, pp. 123-123
Citation: W. Emlen et L. Oneill, COMPARISON OF THE MEASUREMENT OF ANTINUCLEAR ANTIBODIES (ANA) BY IMMUNOFLUORESCENCE AND ELISA, Arthritis and rheumatism, 39(9), 1996, pp. 1578-1578
Citation: W. Emlen, BINDING OF ANTIPHOSPHOLIPID ANTIBODIES TO APOPTOTIC CELLS REQUIRES BETA-2GP1 COFACTOR, Arthritis and rheumatism, 39(9), 1996, pp. 1746-1746
Authors:
LYNCH AM
RUTLEDGE JH
STEPHENS JK
MURPHY JR
MARLAR RA
DAVILA GH
SANTOS ME
EMLEN W
Citation: Am. Lynch et al., LONGITUDINAL MEASUREMENT OF ANTICARDIOLIPIN ANTIBODIES DURING NORMAL-PREGNANCY - A PROSPECTIVE-STUDY, Lupus, 4(5), 1995, pp. 365-369
Authors:
FERGUSON PJ
REIST CJ
MARTIN EN
JOHNSON C
GREENE KL
KUHN S
NIEBUR J
EMLEN W
TAYLOR RP
Citation: Pj. Ferguson et al., ANTIGEN-BASED HETEROPOLYMERS - A POTENTIAL THERAPY FOR BINDING AND CLEARING AUTOANTIBODIES VIA ERYTHROCYTE CR-1, Arthritis and rheumatism, 38(2), 1995, pp. 190-200
Citation: Sg. West et al., NEUROPSYCHIATRIC LUPUS-ERYTHEMATOSUS - A 10-YEAR PROSPECTIVE-STUDY ONTHE VALUE OF DIAGNOSTIC-TESTS, The American journal of medicine, 99(2), 1995, pp. 153-163
Citation: Rw. Erickson et al., TREATMENT OF HEMORRHAGIC LUPUS PNEUMONITIS WITH PLASMAPHERESIS, Seminars in arthritis and rheumatism, 24(2), 1994, pp. 114-123
Citation: Rw. Erickson et al., TREATMENT OF HEMORRHAGIC LUPUS PNEUMONITIS WITH PLASMAPHERESIS, Seminars in arthritis and rheumatism, 24(2), 1994, pp. 114-123
Citation: W. Emlen et al., ACCELERATED IN-VITRO APOPTOSIS OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, The Journal of immunology, 152(7), 1994, pp. 3685-3692
Citation: C. Palmer et al., EXPRESSION OF BCL-2 IN LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical research, 42(1), 1994, pp. 10000025-10000025
Authors:
LYNCH A
MARLAR R
MURPHY J
DAVILA G
SANTOS M
RUTLEDGE J
EMLEN W
Citation: A. Lynch et al., ANTIPHOSPHOLIPID ANTIBODIES IN PREDICTING ADVERSE PREGNANCY OUTCOME -A PROSPECTIVE-STUDY, Annals of internal medicine, 120(6), 1994, pp. 470-475
Citation: W. Emlen, SYSTEMIC LUPUS-ERYTHEMATOSUS AND MIXED CONNECTIVE-TISSUE DISEASE, Immunology and allergy clinics of North America, 13(2), 1993, pp. 291-311
Authors:
HASSELL KL
LYNCH A
MURPHY J
DAVILA G
SANTOS M
RUTLEDGE J
EMLEN W
MARLAR RA
Citation: Kl. Hassell et al., THE PREDICTIVE VALUE OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODIES ASSAYS IN DETERMINING ADVERSE FETAL-OUTCOME, Thrombosis and haemostasis, 69(6), 1993, pp. 1229-1229
Citation: W. Emlen et R. Kadera, PROGRAMMED CELL-DEATH OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, The Journal of immunology, 150(8), 1993, pp. 164-164
Authors:
LYNCH A
RUTLEDGE J
MURPHY J
MARLAR R
DAVILA G
SANTOS M
EMLEN W
Citation: A. Lynch et al., LONGITUDINAL MEASUREMENT OF ANTIPHOSPHOLIPID ANTIBODIES DURING PREGNANCY, Arthritis and rheumatism, 36(9), 1993, pp. 190000075-190000075
Citation: W. Emlen et al., ACCELERATED IN-VITRO APOPTOSIS OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 36(9), 1993, pp. 190000077-190000077
Citation: R. Kadera et W. Emlen, PROGRAMMED CELL-DEATH OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 36(5), 1993, pp. 5-5